Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-14-010558
Filing Date
2014-03-03
Accepted
2014-03-03 16:25:23
Documents
2
Period of Report
2014-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1715
2 POWER OF ATTORNEY poa1.htm EX-24 8182
  Complete submission text file 0001140361-14-010558.txt   11343
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 BERKELEY STREET STE 1650 BOSTON MA 02116
Business Address
CARTHY MARK (Reporting) CIK: 0001286397 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 14660630